Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-18-001224
Filing Date
2018-01-29
Accepted
2018-01-29 21:58:45
Documents
1
Period of Report
2018-01-25

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5566
  Complete submission text file 0001493152-18-001224.txt   7017
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4908 SOUTH ASHTON COURT SPOKANE WA 99223
Business Address
CZIRR JAMES C (Reporting) CIK: 0001260641 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 18557375